APRIL 9, 2013SIX Swiss Exchange, ConventionPoint, Zurich

APRIL 9, 2013SIX Swiss Exchange, ConventionPoint, Zurich12 APRIL 2016Basel Congress Center

Conference Guide

Pic

ture

: Leo

nid

And

rono

v/Fo

tolia

.com

Organised by:

@

“WHITE BIOTECHNOLOGY” WORKING GROUP

Leading chemical companies are exploring the op-portunities that have been opened up by modern bio-technology, especially in the field of “white” or indus-trial biotechnology. And they are also applying thesetechnologies, wherever it makes sense. The SBA takessuch initiatives seriously and has formed a workinggroup specifically dedicated to white biotechnology.The Swiss Industrial Biocatalysis Consortium is animportant partner in this effort. The group includesleading multinational companies that support whitebiotechnology as a pillar of economic growth. Theplanned activities are in agreement with OECD strategies.In partnership with the Swiss Biotechnet (see pages14/15) the SBA develops training programmes and use-ful support tools for the industry. It is of importancethat the industry specifies its training needs so thatthe academic side can create tailor-made education.This strategy ensures that the industry gets the rightworkforce with the right education. The SBA profitsfrom the marketing alliance “Swiss Biotech” (see box)in a multiplied form. Thanks to Swiss Biotech, the

sector is internationally visible. The project-specificparticipating companies (most of them young and in-ternationally less savvy) find a comprehensive partnerwhich is helping to put them in the public window.The participating Life Science Regions are importantinternal carriers of the dynamics in the Biotech sec-tor, thus enhancing the common understanding of theindustry. This and more knowledge is brought intoEuropa Bio, the European Biotech Association, wherethe SBA is an active member.

22

SWISS BIOTECH...

...is an alliance of four leading Biotech regions ofSwitzerland (Bio Alps, BioPolo Ticino, Basel Areaand Greater Zurich Area). They have combined ef-forts to streamline interests of the national biotechsector. The SWX Swiss Exchange holds a leadingposition in terms of lifescience listings and offerscompanies from that industry – be they located inSwitzerland or abroad – access to an international-ly recognised financial marketplace. The initiativewas co-founded by the SBA which also managesthe executive office of Swiss Biotech.

Domenico Alexakis is Executive Director of the Swiss Biotech Association.

...ONE BIOTECH CLUSTER

For further information please visit www.swissbiotechassociation.ch

www.swissbiotech.org

SWISS BIOTECH DAY 2016The leading Life Sciences Conference in Switzerland andAnnual General Assembly of the Swiss Biotech Association

2

SWISS BIOTECH DAY 2016 Programme

Programme

09:00 Registration Opens – Exhibition and Partnering throughout the Day

10:00 General Assembly of the Swiss Biotech Association Room Delhi(by invitation only)

Plenary Session Room Shanghai

Moderation: Monika Jones

11:00 Welcome address Domenico (Nic) Alexakis, CEO, Swiss Biotech Association

11:10 Key Note I: Transforming chemistryRudolf Hanko, CEO, Siegfried AG

11:30 Key Note II: Innovation@Bayer: Combining creative minds with passionMonika Lessl, Head of Innovation Strategy, Bayer AG

11:50 Presentation of the Swiss Biotech Report and panel discussion Jürg Zürcher, Ernst & Young AG and Dominik Escher, President of the Swiss Biotech Association

12:30 Lunch

Free WiFiCongress Center Basel | User-ID: 2143748966 | PW: 6311

#sbd2016

3

Programme SWISS BIOTECH DAY 2016

Investor & Analyst Track Room Delhi

Presentations of Publicly Listed CompaniesModeration: Boris Mannhardt, BIOCOM AG

13:30 Santhera Pharmaceuticals Holding Ltd., Thomas Meier, CEO

14:00 Newron Pharmaceuticals S.p.A., Stefan Weber, CEO

14:30 Addex Therapeutics, Timothy Dyer, CFO

15:00 InnoMedica AG, Jonas Zeller, Head of Finance

15:30 Molecular Partners AG, Andreas Emmenegger, CFO

16:00 Probiodrug AG, Konrad Glund, CEO

16:30 Nordic Nanovector ASA, Luigi Costa, CEO

17:00 Wrap-up of the Day and Apéro at Speaker’s Corner – hosted by Bayer AG

4

SWISS BIOTECH DAY 2016 Programme

Innovations in Healthcare Room Shanghai

Emerging Biotech CompaniesModeration: Monika Lessl, Bayer AG and Tom Woiwode, Versant Ventures

13:30 Genkyotex S.A., Elias Papatheodorou, CEO

13:45 Quartz Bio S.A., Jérôme Wojcik, CEO

14:00 Gour Medical S.A., Serge Goldner, CEO

14:15 Tolerys S.A., Pierre-Marie Guyonvarc'h, CEO

14:30 Inthera Bioscience AG, Ulrich Kessler, CEO

14:45 ChondroNest S.A., Thierry Schwitzguébel, CEO

15:00 Memo-Therapeutics AG, Armin W. Mäder, CEO

15:15 MaxiVax, Nicolas Mach, CSO

15:30 End

17:00 Wrap-up of the Day and Apéro at Speaker’s Corner – hosted by Bayer AG

Presented by

5

Programme SWISS BIOTECH DAY 2016

Impacts on the Value Chain Room Kairo

Impulse: Life ScienceModeration: Monika Jones

13.30 Welcome Alberto Silini, Head of Consultancy, Switzerland Global Enterprise

13.45 Introduction on Value Chains in BiotechValue chain management in the biosciences industryHans Mies, Director KPMG Switzerland, Head Value Chain Management

14.15 New Markets: International CooperationsInternational cooperation as a business modelJakob Dynnes Hansen, CFO, EvolvaNew Markets – benefits of international R&D cooperationAndreas Gut, Swiss EUREKA Project Coordinator,State Secretariat for Education, Research and Innovation SERI

15:15Innovation: Technology Fusion: Biotech meets ITHome use blood testing platform for the prevention of cardiovascular diseasesArthur Queval, Founder & CEO, Qloudlab

15:45 Processes and Structures: Lean and mean: Biotech structures in SwitzerlandLiv Minder, Director Investment Promotion, Switzerland Global Enterprise

16:15 Panel Discussion

16:50 Summary

17:00 Wrap-up of the Day and Apéro at Speaker’s Corner – hosted by Bayer AG

Presented by

6

SWISS BIOTECH DAY 2016 Programme

Compliance Risk Management Room Boston

The Right Balance between too much and too little – Compliance – Get InspiredModeration: Martin Rohrbach, KPMG AG

13.30 Introduction Martin Rohrbach, Partner & Head of Audit Basel, KPMG AG

13.40 Impact of emerging regulations, codes and guidelines on how biotech companies conduct business Kathleen Tench, Director Forensic, KPMG AG

14.00 When does compliance become a management principle? Peter Herrmann, CCO, Actelion Pharmaceuticals Ltd.

14:30 Compliance programme for early research functions Jan Wesiack, Regional Compliance Manager Europe, NIBR Basel, Novartis Pharma AG

14:45 Research with human biological material and data Adrian Zumbach, Senior Legal Counsel NIBR Basel, Novartis Pharma AG

15.00 Coffee Break

15.30 Structuring the insurance portfolio of life science companies Jörg Schmidt, Schmidt Versicherungs Treuhand AG

16.00 Ethics as a business case for the right balance in compliance Martijn de Kiewit, Director Forensic, KPMG AG

17:00 Wrap-up of the Day and Apéro at Speaker’s Corner – hosted by Bayer AG

Presented by

7

Exhibitors / Partnering Rooms SWISS BIOTECH DAY 2016

Exhibitors

Partnering Rooms

AnaPath GmbH / Accelera Srl . . . . . . 5

Aseptic Technologies S.A. . . . . . . . . . 11

BIOCOM AG . . . . . . . . . . . . . . . . . . . . 16

BIOMAPAS . . . . . . . . . . . . . . . . . . . . . 3

Cobra Biologics . . . . . . . . . . . . . . . . . 10

Fujifilm Diosynth Biotechnologies . . . . 8

Hamamatsu Photonics France . . . . . . 14

InnoMedica AG . . . . . . . . . . . . . . . . . . 2

LSZYSN . . . . . . . . . . . . . . . . . . . . . . . 13

M+W Central Europe GmbH . . . . . . . . 18

NNE Pharmaplan . . . . . . . . . . . . . . . . 15

PCI Pharma Services . . . . . . . . . . . . . 12

Pro Farma AG . . . . . . . . . . . . . . . . . . 7

Merck / Sigma-Aldrich . . . . . . . . . . . . 19

SIX Swiss Exchange AG . . . . . . . . . . . 20

Swiss Biotech Association . . . . . . . . . 17

Switzerland Global Enterprise . . . . . . . 1

Tepnel Pharma Services . . . . . . . . . . . 4

Wirtschaftsförderung Sachsen . . . . . . 9

Booth No. Booth No.

Johnson & Johnson . . . . . . . . . . . . . . 1 Invest in MV . . . . . . . . . . . . . . . . . . . . 2

8

SWISS BIOTECH DAY 2016 Floor Map

Floor Map

Room Shanghai

Room Boston

Room Delhi

Restrooms

2

Par

tner

ing

Des

kVenue:Congress Center BaselHall 4Messeplatz 214058 Basel, Switzerland

Exhibitors Stands Partnering Booths Partnering Tables Partnering Rooms

Room Kairo

1

2

21

34

56

7

89 10 11 12

15 14 13

16

17

20 19 18 17 16

9

Floor Map SWISS BIOTECH DAY 2016

Catering

Catering

Catering

Registration

Med

ia T

able

➔Entrance

Rie

hens

trass

e / M

esse

plat

zWardrobe

Speaker’sCorner

18

19

20

2 3 4 5

1

11

10

9

8

7

6

15

14

13

12

Sponsors:

Organised by:

@

“WHITE BIOTECHNOLOGY” WORKING GROUP

Leading chemical companies are exploring the op-portunities that have been opened up by modern bio-technology, especially in the field of “white” or indus-trial biotechnology. And they are also applying thesetechnologies, wherever it makes sense. The SBA takessuch initiatives seriously and has formed a workinggroup specifically dedicated to white biotechnology.The Swiss Industrial Biocatalysis Consortium is animportant partner in this effort. The group includesleading multinational companies that support whitebiotechnology as a pillar of economic growth. Theplanned activities are in agreement with OECD strategies.In partnership with the Swiss Biotechnet (see pages14/15) the SBA develops training programmes and use-ful support tools for the industry. It is of importancethat the industry specifies its training needs so thatthe academic side can create tailor-made education.This strategy ensures that the industry gets the rightworkforce with the right education. The SBA profitsfrom the marketing alliance “Swiss Biotech” (see box)in a multiplied form. Thanks to Swiss Biotech, the

sector is internationally visible. The project-specificparticipating companies (most of them young and in-ternationally less savvy) find a comprehensive partnerwhich is helping to put them in the public window.The participating Life Science Regions are importantinternal carriers of the dynamics in the Biotech sec-tor, thus enhancing the common understanding of theindustry. This and more knowledge is brought intoEuropa Bio, the European Biotech Association, wherethe SBA is an active member.

22

SWISS BIOTECH...

...is an alliance of four leading Biotech regions ofSwitzerland (Bio Alps, BioPolo Ticino, Basel Areaand Greater Zurich Area). They have combined ef-forts to streamline interests of the national biotechsector. The SWX Swiss Exchange holds a leadingposition in terms of lifescience listings and offerscompanies from that industry – be they located inSwitzerland or abroad – access to an international-ly recognised financial marketplace. The initiativewas co-founded by the SBA which also managesthe executive office of Swiss Biotech.

Domenico Alexakis is Executive Director of the Swiss Biotech Association.

...ONE BIOTECH CLUSTER

For further information please visit www.swissbiotechassociation.ch

www.swissbiotech.org

In cooperation with:

Media Partner:Supporting Partners:

Thanks to our Sponsors!